This paper is in the following e-collection/theme issue:

Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (832) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Pharmacovigilance (134)

Published on in Vol 21, No 10 (2019): October

An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study

An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study

An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study

Authors of this article:

Joshua Curtis Black1 Author Orcid Image ;   Karilynn Rockhill1 Author Orcid Image ;   Alyssa Forber1 Author Orcid Image ;   Elise Amioka1 Author Orcid Image ;   K Patrick May1 Author Orcid Image ;   Colleen M Haynes1 Author Orcid Image ;   Nabarun Dasgupta1, 2 Author Orcid Image ;   Richard C Dart1 Author Orcid Image
Article Authors Cited by (20) Tweetations (6) Metrics

Journals

  1. Hockenhull J, Black J, Haynes C, Rockhill K, Dargan P, Dart R, Wood D. Nonmedical use of benzodiazepines and Z‐drugs in the UK. British Journal of Clinical Pharmacology 2021;87(4):1676 View
  2. Hockenhull J, Amioka E, Black J, Forber A, Haynes C, Wood D, Dart R, Dargan P. Non‐medical use of benzodiazepines and GABA analogues in Europe. British Journal of Clinical Pharmacology 2021;87(4):1684 View
  3. Schimmel J, Amioka E, Rockhill K, Haynes C, Black J, Dart R, Iwanicki J. Kratom use in the United States: Response to Grundmann et al.. Addiction 2021;116(1):203 View
  4. Schimmel J, Amioka E, Rockhill K, Haynes C, Black J, Dart R, Iwanicki J. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross‐sectional study. Addiction 2021;116(1):176 View
  5. Iwanicki J, Schwarz J, May K, Black J, Dart R. Tramadol non-medical use in Four European countries: A comparative analysis. Drug and Alcohol Dependence 2020;217:108367 View
  6. Wood D, Dargan P. Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuse. British Journal of Clinical Pharmacology 2021;87(4):1654 View
  7. Dart R, Iwanicki J, Black J, Olsen H, Severtson S. Measuring prescription opioid misuse and its consequences. British Journal of Clinical Pharmacology 2021;87(4):1647 View
  8. Fonseca F, Lenahan W, Dart R, Papaseit E, Dargan P, Wood D, Guareschi M, Maremmani I, Auriacombe M, Farré M, Scherbaum N, Torrens M. Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries. Frontiers in Psychiatry 2021;12 View
  9. Black J, Forber A, Severtson S, Rockhill K, May K, Amioka E, Schwarz J, Iwanicki J, Dart R. Drug product dispensing and estimates of use in a general population survey as a signal detection problem. Pharmacoepidemiology and Drug Safety 2021;30(8):1132 View
  10. Powers J, Lape E, LaRowe L, Hooker J, Heckman B, Ditre J. Initial Validation of the Intentions to Co-Use Alcohol and Opioids Scale. Journal of Psychoactive Drugs 2023;55(3):369 View
  11. Black J, Amioka E, Iwanicki J, Dart R, Monte A. Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks. JAMA Network Open 2022;5(11):e2240526 View
  12. Hockenhull J, Wood D, Fonseca F, Guareschi M, Scherbaum N, Iwanicki J, Dart R, Dargan P. The association between the availability of over the counter codeine and the prevalence of non-medical use. European Journal of Clinical Pharmacology 2022;78(6):1011 View
  13. Lape E, Powers J, Hooker J, Edwards R, Ditre J. Benzodiazepine Use and Dependence in Relation to Chronic Pain Intensity and Pain Catastrophizing. The Journal of Pain 2023;24(2):345 View
  14. Black J, Schow N, Burkett H, Pena M, Jewell J, Czizik A, Monte A, Dart R. Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness. International Journal of Mental Health and Addiction 2023 View
  15. Rockhill K, Olson R, Dart R, Iwanicki J, Black J. Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. Journal of Medical Internet Research 2023;25:e46742 View
  16. Black J, Burkett H, Rockhill K, Olson R, Dart R, Iwanicki J. Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis. Journal of Medical Internet Research 2023;25:e46747 View
  17. Ellis M, Buttram M, Forber A, Black J. Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States. Journal of Psychoactive Drugs 2024;56(3):333 View
  18. Monte A, Schow N, Black J, Bemis E, Rockhill K, Dart R. The Rise of Psychedelic Drug Use Associated With Legalization/Decriminalization: An Assessment With the Nonmedical Use of Prescription Drugs Survey. Annals of Emergency Medicine 2024;83(3):283 View
  19. Jewell J, Bemis E, Black J. Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population. Journal of Addiction Medicine 2024;18(4):466 View
  20. Simon M, Olsen H, Hoyte C, Black J, Reynolds K, Dart R, Monte A. Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022. Annals of Emergency Medicine 2024;84(6):605 View